RLMD
Relmada Therapeutics, Inc. Common Stock
$2.14
-5.88%
-0.13
Notify me if price changes either direction
Buy RLMD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
73.6M
Enterprise value
53.7M
Trailing PE
-0.79543392613249
Forward PE
-1.0646766
PEG Ratio
0.016182966083385
Enterprise to EBITDA
-0.63756938976333
Price to book MRQ
4.4490647
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Diluted EPS TTM
-2.2
Total Cash (MRQ)
20.6M
Current ratio (MRQ)
4.108
Operating Cash Flow (TTM)
-49924936
RLMD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
